B. Yogi Sreenivas

Ultrasound-based approach to spiro-2,3-dihydroquinazolin-4(1H)-ones: their in vitro evaluation against chorismate mutase

D. Rambabu, Sarvesh Kumar, B. Yogi Sreenivas et al. · Tetrahedron Letters · 2012 · 66 citations

Medicinal Chemistry, Chorismate Mutase, Ultrasound-based Approach +5

Spiro heterocycles as potential inhibitors of SIRT1: Pd/C-mediated synthesis of novel N-indolylmethyl spiroindoline-3,2′-quinazolines

D. Rambabu, Guttikonda Raja, B. Yogi Sreenivas et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 52 citations · Full text

Novel N-indolylmethyl Spiroindoline-3,2′-quinazolines, Medicinal Chemistry, Biochemistry +9

Rivastigmine and metabolite analogues with putative Alzheimer’s disease-modifying properties in a Caenorhabditis elegans model

Satish N. Dighe, E. De la Mora, Stephen Chan et al. · Communications Chemistry · 2019 · 34 citations · Full text

Conformationally restricted functionalized heteroaromatics: a direct access to novel indoloindoles via Pd-mediated reaction

Bagineni Prasad, B. Yogi Sreenivas, D. Rambabu et al. · Chemical Communications · 2013 · 32 citations

Novel Indoloindoles, Organic Chemistry, Chemistry +17

C–C bond formation at C-2 of a quinoline ring: Synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors

K. Shiva Kumar, Sarvesh Kumar, B. Yogi Sreenivas et al. · Bioorganic & Medicinal Chemistry · 2012 · 28 citations · Full text

Pde4 Inhibitors, Medicinal Chemistry, Natural Sciences +8